aTYR PHARMA INC (ATYR) Total liabilities 2019–2025
aTYR PHARMA INC (ATYR) total liabilities at each fiscal year-end, per SEC filings.
$25.5MFY2025 · since FY2019: $15.0M → $25.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $25.5M | -4.8% |
| FY2024 | $26.8M | -10.6% |
| FY2023 | $30.0M | +23.3% |
| FY2022 | $24.3M | +290.0% |
| FY2021 | $6.2M | -11.9% |
| FY2020 | $7.1M | -52.8% |
| FY2019 | $15.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ATYR financial trends
ATYR RevenueATYR Net incomeATYR Net marginATYR Gross profitATYR Gross marginATYR Operating incomeATYR Operating marginATYR Operating cash flowATYR Free cash flowATYR Capital expendituresATYR Return on equityATYR Stock buybacksATYR Dividends paidATYR Total assetsATYR Shareholders’ equityATYR overview →